Franklin Street Advisors Inc Tyme Technologies, Inc. Transaction History

Franklin Street Advisors Inc

  • $1.48 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 21, 2020
SELL
$0.93 - $1.35 $1,860 - $2,700
-2,000 Reduced 4.76%
40,000 $39,000
Q4 2018

Feb 14, 2019
BUY
$2.01 - $4.21 $2,009 - $4,210
1,000 Added 2.44%
42,000 $155,000
Q2 2018

Jul 16, 2018
BUY
$2.05 - $4.09 $20,500 - $40,900
10,000 Added 32.26%
41,000 $130,000
Q4 2017

Jan 10, 2018
BUY
$3.25 - $7.3 $100,750 - $226,300
31,000
31,000 $198,000

About TYME TECHNOLOGIES, INC.

TYME Quotes by TradingView
  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track Franklin Street Advisors Inc Portfolio

Follow Franklin Street Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Street Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Franklin Street Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email